FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073566101> ?p ?o ?g. }

• W2073566101 endingPage "1876" @default.
• W2073566101 startingPage "1871" @default.
• W2073566101 abstract "Autoantibodies to steroidogenic enzymes, steroid 17 alpha-hydroxylase (17 alpha-OH), cytochrome P450 side-chain cleavage enzyme (P450scc), and steroid 21-hydroxylase (21-OH), were measured using specific and sensitive immunoprecipitation assays (IPAs) in patients with various forms of autoimmune adrenal disease. Autoantibodies to 17 alpha-OH were detected in 6 of 11 (55%) patients with autoimmune polyglandular syndrome (APS) type I, 8 of 24 (33%) patients with APS type II, 11 of 56 (20%) patients with adrenal cortex antibody (ACA; measured by immunofluorescence)-positive patients without Addison's disease, and only 3 of 64 (5%) patients with Addison's disease. Autoantibodies to P450scc were found at a prevalence similar to those to 17 alpha-OH: in 5 of 11 (45%) APS type I patients, 10 of 24 (42%) APS type II patients, 11 of 56 (20%) ACA-positive patients without Addison's disease, and only 6 of 64 (9%) patients of the Addison disease group. Autoantibodies to 21-OH were found in a majority of patients with APS type I (7 of 11;64%), APS type II (23 of 24; 96%), Addison's disease (41 of 64; 64%), and ACA-positive patients without Addison's disease (48 of 56; 86%). All sera that were positive for 17 alpha-OH or P450scc were also positive for 21-OH autoantibodies, except in 1 case. There was good agreement between the presence of ACA measured by immunofluorescence and 21-OH antibodies measured by IPA in all patient groups studied, and this indicates that 21-OH is a major autoantigen in adrenal autoimmune disease regardless of whether the disease presents as isolated Addison's disease or APS type I or type II. Autoantibodies to 17 alpha-OH and P450scc appeared to be the major components of the steroid-producing cell antibodies measured by immunofluorescence. No autoantibodies to 21-OH, 17 alpha-OH, or P450scc were detected in 17 sera from patients with premature ovarian failure without evidence of adrenal autoimmunity (as judged by immunofluorescence studies), except for 1 serum in which low levels of 17 alpha-OH antibodies were found. Overall, our studies indicate that 35S-labeled 17 alpha-OH, P450scc, and 21-OH can be used successfully in IPAs for their respective autoantibodies. Assays such as these may well be valuable in the immunological assessment of patients at risk for or suspected of adrenal autoimmunity." @default.
• W2073566101 created "2016-06-24" @default.
• W2073566101 creator A5004876607 @default.
• W2073566101 creator A5020370414 @default.
• W2073566101 creator A5025809987 @default.
• W2073566101 creator A5030410833 @default.
• W2073566101 creator A5046211779 @default.
• W2073566101 creator A5055004417 @default.
• W2073566101 creator A5070082165 @default.
• W2073566101 creator A5077619835 @default.
• W2073566101 date "1996-05-01" @default.
• W2073566101 modified "2023-09-27" @default.
• W2073566101 title "Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure." @default.
• W2073566101 cites W1487519265 @default.
• W2073566101 cites W1969614224 @default.
• W2073566101 cites W1974439470 @default.
• W2073566101 cites W1979725693 @default.
• W2073566101 cites W1990429184 @default.
• W2073566101 cites W1996805667 @default.
• W2073566101 cites W1999925956 @default.
• W2073566101 cites W2028393908 @default.
• W2073566101 cites W2038565641 @default.
• W2073566101 cites W2043489741 @default.
• W2073566101 cites W2081502384 @default.
• W2073566101 cites W2088454583 @default.
• W2073566101 cites W2167906324 @default.
• W2073566101 cites W2171922298 @default.
• W2073566101 doi "https://doi.org/10.1210/jcem.81.5.8626850" @default.
• W2073566101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8626850" @default.
• W2073566101 hasPublicationYear "1996" @default.
• W2073566101 type Work @default.
• W2073566101 sameAs 2073566101 @default.
• W2073566101 citedByCount "95" @default.
• W2073566101 countsByYear W20735661012012 @default.
• W2073566101 countsByYear W20735661012013 @default.
• W2073566101 countsByYear W20735661012014 @default.
• W2073566101 countsByYear W20735661012015 @default.
• W2073566101 countsByYear W20735661012016 @default.
• W2073566101 countsByYear W20735661012017 @default.
• W2073566101 countsByYear W20735661012018 @default.
• W2073566101 countsByYear W20735661012019 @default.
• W2073566101 countsByYear W20735661012020 @default.
• W2073566101 countsByYear W20735661012021 @default.
• W2073566101 countsByYear W20735661012022 @default.
• W2073566101 countsByYear W20735661012023 @default.
• W2073566101 crossrefType "journal-article" @default.
• W2073566101 hasAuthorship W2073566101A5004876607 @default.
• W2073566101 hasAuthorship W2073566101A5020370414 @default.
• W2073566101 hasAuthorship W2073566101A5025809987 @default.
• W2073566101 hasAuthorship W2073566101A5030410833 @default.
• W2073566101 hasAuthorship W2073566101A5046211779 @default.
• W2073566101 hasAuthorship W2073566101A5055004417 @default.
• W2073566101 hasAuthorship W2073566101A5070082165 @default.
• W2073566101 hasAuthorship W2073566101A5077619835 @default.
• W2073566101 hasBestOaLocation W20735661011 @default.
• W2073566101 hasConcept C126322002 @default.
• W2073566101 hasConcept C134018914 @default.
• W2073566101 hasConcept C159654299 @default.
• W2073566101 hasConcept C163764329 @default.
• W2073566101 hasConcept C203014093 @default.
• W2073566101 hasConcept C2777817097 @default.
• W2073566101 hasConcept C2777977426 @default.
• W2073566101 hasConcept C2778129406 @default.
• W2073566101 hasConcept C2779075594 @default.
• W2073566101 hasConcept C2779134260 @default.
• W2073566101 hasConcept C2780130043 @default.
• W2073566101 hasConcept C526171541 @default.
• W2073566101 hasConcept C62231903 @default.
• W2073566101 hasConcept C71924100 @default.
• W2073566101 hasConcept C80446465 @default.
• W2073566101 hasConceptScore W2073566101C126322002 @default.
• W2073566101 hasConceptScore W2073566101C134018914 @default.
• W2073566101 hasConceptScore W2073566101C159654299 @default.
• W2073566101 hasConceptScore W2073566101C163764329 @default.
• W2073566101 hasConceptScore W2073566101C203014093 @default.
• W2073566101 hasConceptScore W2073566101C2777817097 @default.
• W2073566101 hasConceptScore W2073566101C2777977426 @default.
• W2073566101 hasConceptScore W2073566101C2778129406 @default.
• W2073566101 hasConceptScore W2073566101C2779075594 @default.
• W2073566101 hasConceptScore W2073566101C2779134260 @default.
• W2073566101 hasConceptScore W2073566101C2780130043 @default.
• W2073566101 hasConceptScore W2073566101C526171541 @default.
• W2073566101 hasConceptScore W2073566101C62231903 @default.
• W2073566101 hasConceptScore W2073566101C71924100 @default.
• W2073566101 hasConceptScore W2073566101C80446465 @default.
• W2073566101 hasIssue "5" @default.
• W2073566101 hasLocation W20735661011 @default.
• W2073566101 hasLocation W20735661012 @default.
• W2073566101 hasOpenAccess W2073566101 @default.
• W2073566101 hasPrimaryLocation W20735661011 @default.
• W2073566101 hasRelatedWork W1949704252 @default.
• W2073566101 hasRelatedWork W2014921920 @default.
• W2073566101 hasRelatedWork W2052710199 @default.
• W2073566101 hasRelatedWork W2059412274 @default.
• W2073566101 hasRelatedWork W2073566101 @default.
• W2073566101 hasRelatedWork W2075762793 @default.
• W2073566101 hasRelatedWork W2096448574 @default.
• W2073566101 hasRelatedWork W2129043014 @default.

• next